Enovis CORP (ENOV) company profile
Close on Nov 18, 2026Market cap $1.56BP/E –Yield –
About Enovis
Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842
Enovis Corporation is a medical technology company that develops, manufactures, and distributes medical devices across the care continuum, from injury prevention to joint replacement and post-operative rehabilitation. The company operates through two segments: Prevention & Recovery, and Reconstructive. The Prevention & Recovery segment provides orthopedic braces, temperature therapies, bone growth stimulators, compression garments, and pain management equipment. The Reconstructive segment supplies surgical implants, instrumentation, and digital planning technologies for joint replacement and limb reconstruction. Enovis serves orthopedic specialists, surgeons, physical therapists, healthcare systems, and retail consumers.
The company conducts business internationally, with primary geographic markets in the United States and Europe, alongside operations in the Asia-Pacific region. Products are distributed globally through direct sales personnel and independent distributor networks. Enovis also sources raw materials and component parts from diverse global suppliers. The provided text does not state the location of the company's corporate headquarters.
Summary of the business section of Enovis's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Enovis CORP
- Founded
- 1998
- Headquarters
- Lewisville, TX
- Address
- 2900 Lake Vista Drive, Suite 200 75067
- Phone
- (302) 252-9160
- Website
- enovis.com
- Employees
- 7,802, Dec 31, 2025
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, Philadelphia, Pennsylvania
Stock & identifiers
- Ticker
- ENOV
- Former tickers
- CFX until Apr 8, 2022
- Exchange
- NYSE
- IPO date
- May 8, 2008
- Shares outstanding
- 58M, Jul 31, 2026
- Public float
- $1.91B, Jul 4, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 1-for-3 reverse, May 10, 2022
- SEC CIK
- 1420800
- CUSIP
- 194014502
- ISIN
- US1940145022
- FIGI
- BBG000C5Z443
- Share class FIGI
- BBG001SC04J1
- LEI
- 635400OP2DYYYMOIYL17
- EIN
- 54-1887631
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Damien McDonald | Chief Executive Officer, Director | 247,077 |
| Matthew L. Trerotola | CEO, Director | 373,514 |
| Oliver Engert | Chief Administrative Officer | 63,898 |
| Phillip Benjamin (Ben) Berry | SVP, Chief Financial Officer | 150,822 |
| Laura Lee Singleton | SVP, Chief HR Officer | 15,552 |
| Patricia A. Lang | SVP, Chief HR Officer | 75,703 |
| Bradley J. Tandy | SVP and Chief Legal Officer | 65,641 |
| John Kleckner | Principal Accounting Officer | 25,884 |
| Terry D. Ross | GROUP PRESIDENT, P&R | 68,477 |
| Louis Vogt | GROUP PRESIDENT, RECON | 68,875 |
| Angela S. Lalor | Director | 34,997 |
| Sharon L. Wienbar | Director | 45,551 |
| Christine Ortiz | Director | 26,815 |
| Rajiv Vinnakota | Director | 37,608 |
| A. Clayton Perfall | Director | 56,672 |
| Barbara W. Bodem | Director | 24,201 |
| Philip Okala | Director | 24,201 |
| Brady Shirley | Director | 110,589 |
| Liam Kelly | Director | 28,950 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Peo1 | $9.24M | $6.13M | $2.93M | $41 | $79 |
| FY2025 Peo2 | $9.42M | $1.47M | $2.93M | $41 | $79 |
| FY2024 Peo | $12.45M | $4.87M | $2.78M | $67 | $79 |
| FY2024 Peo2 | $12.45M | $4.87M | $2.78M | $67 | $79 |
| FY2023 Peo | $10.77M | $11.81M | $3.60M | $85 | $75 |
| FY2023 Peo2 | $10.77M | $11.81M | $3.60M | $85 | $75 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Damien McDonald Chief Executive Officer | $634.62K | $7.26M | $812.75K | $532.15K | $9.24M | – |
| Matthew L. Trerotola Executive Advisor – former Chief Executive Officer | $857.46K | $7.27M | $988.22K | $305.46K | $9.42M | -24% |
| Phillip “Ben” Berry Chief Financial Officer | $604.92K | $4.03M | $464.00K | $36.85K | $5.14M | +50% |
| Daniel A. Pryor Former Executive Vice President, Strategy and Business Development | $614.92K | $1.87M | $457.31K | $89.24K | $3.03M | -14% |
| Terry Ross Group President, P&R | $514.92K | $1.40M | $388.62K | $65.86K | $2.37M | – |
| Patricia Lang Senior Vice President and Chief Human Resources Officer | $502.46K | $1.15M | $358.52K | $67.86K | $2.08M | -10% |
| Louis Vogt Group President Recon | $500.00K | $1.17M | $344.63K | $22.50K | $2.03M | – |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- May 8, 2008
- Offer price
- $18.00
- Securities offered
- 18,750,000
- Gross proceeds
- $337.50M
- Exchange
- NYSE
- First trading day
- May 8, 2008
- First-day close
- $63.00+250.0%
- Lock-up ends (est.)
- Nov 4, 2008
“Per Share Total Public offering price $18.00 $ 337,500,000 Underwriting discount $1.215 $22,781,250 Proceeds, before expenses, to Colfax Corporation $ 16.785 $ 151,731,902 Proceeds, before expenses, to the selling stockholders (1) $ 16.785 $ 162,986,848 (1) The selling stockholders are Mitchell P.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed approximately 7,802 persons, of whom approximately 2,107 were employed in the United States and approximately 5,695 were employed outside of the United States.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?